Most folks that read my stuff know that I don't say things without a lot of research, so I'm gonna lay a bit of it on ya
I don't like or condone the antics of big pharma, but am thankful that GW pharma gets to experiment with MJ and post their findings
the following quotes are from one such study
Specific Methods
5.4.2.1 Uniformity of Plants Grown from Cuttings or Seed
THC variety G1 was selected for this test. Thirty plants raised from cuttings were compared to a similar number raised from seeds. The clones were all derived from one plant and code named clone M1. For the seed sown crop, seedlings were raised as described in paragraph 5.4.1.1. For the plants raised from cuttings, the propagation timings and conditions were as described in paragraph 5.4.1.2. Ten days after sowing, eighty individual seedlings were transplanted into pots using identical materials and methods employed for the propagation of plants from cuttings. The rooted cuttings were also transplanted on the same day.
Three weeks after transplanting, the plants were moved to a twelve hour light / twelve hour dark regime to induce flowering. All male plants and excess female plants were removed to leave thirty seed and thirty clone derived plants. These were maintained in neighbouring blocks at a density of ten plants per square metre. Eight weeks after the move to twelve hour days, the plants were harvested and dried. The total weight of foliar and floral material produced by each plant after removal of the stem was recorded. This mixture was then milled and the cannabinoid content studied using gas chromatography.
Two clones used for the production of clinical trials raw material were selected viz. M1 and M7. Twelve commercially available varieties were also selected. All were commonly used for illicit recreational purposes and were described as being derived from tropical or subtropical areas. Plants truly derived from these contrasting locations would be expected to differ in the natural duration of their flowering period.
Seedlings of each of the twelve commercial varieties were raised in the glasshouse in a twenty-four hour daylength. When sufficiently developed, cuttings were taken from each plant and encouraged to root using the standard method (section 5.4.2). The original plants, from which the cuttings were taken, were moved to a twelve-hour daylength regime to encourage flowering. All plants consequently identified as male were disposed of along with all cuttings taken from them prior to gender identification. Up to three female clone lines of each variety were retained for further evaluation, each being regarded as the most potent or prolifically flowering examples of their variety. Just one clone line was chosen for evaluation from four of the varieties. Two or three clone lines were selected from the remainder. In the latter case, these varieties had shown a high level of phenotypic variability.
The propagation regime was based on that used for regular production of THC for clinical trial (Section 5.4.2 – 5.4.
. However, a temporary installation of supplementary glasshouse lights was in place for this test and this gave a slightly lower minimum irradiance level of 40 W m-2 PAR.
Fifteen plants of each clone were propagated and five of each harvested after six, eight and ten weeks in flower. Harvested plants were dried in a dehumidified environment (final humidity < 35%) for seven days and the floral and foliar material stripped from the stem. The floral and foliar material of the five replicate plants of each clone line were thoroughly mixed. Five small samples of approximately 1 g were taken at random from the mixture, blended and analysed by High Performance Liquid Chromatography (Appendix 1).
All plants were propagated in the glasshouse using the standard materials and methods. Eighty plants of each selected clone line were grown in five-litre pots and maintained in constant twenty-four hour daylength for the first three weeks after potting. Thereafter half were transferred to a glasshouse area with a twelve-hour daylength and the remainder relocated to a similar glasshouse area with a thirteen-hour daylength regime. In both areas the glasshouse target irradiance level was 75 Wm-2. Within each regime, each clone line was divided into two batches of twenty plants. Single plant
batches of each clone line were placed alongside each other at a pot-density of 10 m-2. Plants were watered by hand throughout the test. Eight weeks after the move to short daylength, one batch of each clone was harvested and hung to dry. The remaining batches were harvested and dried fourteen days later.
NOTE: that 3 seperate harvest were taken (why I bolded it)
Then they did the test,,,,,,,
Comparison of the Yield and Uniformity of Plants Grown from Cuttings or Seeds
The yield of raw material obtained from plants grown from seed (494 g m-2) and cuttings (515 g m-2) was very similar. An analysis of variance (n = 30) showed this small difference not to be significant (p > 0.05). However, the mean THC content of the cloned plants (14.6% THC w/w) was significantly higher (ANOVA, p < 0.01) than those grown from seed (11.1% THC). As a consequence, the cloned plants produced significantly more THC per unit area - 75.4 g m-2 (p < 0.01, ANOVA) than those from seed - 54.9 g m-2. Clone M1 was one of five originally selected for further testing from approximately one hundred female plants of the variety G1. The selection was on the basis of its favourable ratings for vigour, yield, glandular trichome density, THC content and purity. The THC content of these one hundred plants had exhibited a normal distribution. It is not clear from this investigation whether the increased THC yield from the cloned material was entirely as a result of this selection process.
Only THC, CBG and CBC were found in detectable quantities in all samples. The mean CBG content seed sown plants was very similar to that collected from cloned plants, and no significant difference was found. Although the mean CBC content of cloned plants was 15% higher than that of seed derived plants, this increase was not significant (ANOVA, p > 0.05). F-tests showed the CBC potency of seed derived plants to be significantly more variable (p < 0.01). The difference in variability of CBG content of seed sown plants was much less pronounced. Seed derived plants were not significantly more variable in CBG potency than those raised from clones (p > 0.05). When the ratios of cannabinoids in the seed-sown and cloned plants were compared it was found that the cannabinoid profile of seeds-sown plants was more variable than that those raised from cuttings. F-tests showed that the CBC:THC ratio and CBG:THC ratios to be significantly more variable in plants grown from seed (p < 0.01).
NOTE: there is NO CBN indicated !!!
The forum nonsense about amber trics being a signal that THC is degrading to CBN is MYTH and beyond bullshit
I also like the point made that the clones had more THC than the from seed plants showing that allowing longer veg times on seeds is a must to reach plant maturity before flowering !!!